Eli Lilly CEO David Ricks breaks down Q1 earnings, obesity drug trial results

Eli Lilly CEO David Ricks joins CNBC's Meg Tirrell and the 'Squawk Box' team to break down the company's latest earnings record and its medical test results for weight-loss medication tirzepatide. Subscribe to CNBC: https://cnb.cx/SubscribeCNBC. Count On CNBC television for the most recent securities market information as well as analysis. From market futures to live rate updates CNBC is the leader in organization news worldwide. The News with Shepard Smith is CNBC's day-to-day information podcast providing deep, non-partisan coverage as well as viewpoint on the day's most vital tales. Readily available to listen by 8:30 pm ET/ 5:30 pm PT daily start September 30: https://www.cnbc.com/2020/09/29/the-news-with-shepard-smith-podcast.html?__source=youtube%7Cshepsmith%7Cpodcast  . Get In Touch With CNBC News Online. Get the most up to date information: http://www.cnbc.com/. Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC. Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC. Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC. Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC. https://www.cnbc.com/select/best-credit-cards/ . #CNBC. #CNBCTV.

Leave a Reply

Your email address will not be published.